COMP <GO>
FEMY vs NMTC // EV/EBITDA & P/E VALUATION
Femasys Inc. (NASDAQ) VS. NeuroOne Medical Technologies Corporation (NASDAQ) • 15-METRIC TALLY: FEMY 2
— NMTC 5
■ METRIC PARITY
LAST: $1.36 (-3.90%) • MKT CAP: $11.3M
valuation
—
LAST: $0.97 (+12.96%) • MKT CAP: $8.8M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FEMY VS. NMTC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FEMY | NMTC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.00% | 56.50% | +5.50 | FEMY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -46.50% | -13.50 | NMTC | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -39.60% | -20.40 | NMTC | /net-margins <GO> |
| Revenue Growth (YoY) | 40.80% | 163.50% | -122.70 | NMTC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | NMTC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.5 | 40.1 | -12.58 | NMTC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.3M | $8.8M | $2.5M | FEMY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FEMY REV | NMTC REV | FEMY GROSS % | NMTC GROSS % | FEMY FCF | NMTC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.3M | $9.1M | 62.0% | 56.5% | -$19.2M | -$2.9M |
| FY 2024 | $1.6M | $3.5M | 66.6% | 31.3% | -$20.2M | -$11.1M |
| FY 2023 | $1.1M | $2.0M | — | — | -$11.3M | -$12.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FEMY // BETA —
NMTC // BETA —